Orexo to Present at the Annual Biotech Showcase Conference, San Francisco
Uppsala, Sweden, December 19, 2016 – Orexo AB (publ.), announced today that it will present at the 9th Annual Biotech Showcase Conference being held January 9-11, 2017 in San Francisco, CA. Nikolaj Sørensen, President and CEO of Orexo AB, will present the business, focusing on the driving forces behind the global opioid addiction treatment market, the development of Zubsolv® in the US and the progress towards launching in the rest of the world. An overview will also be given of Orexo’s pipeline of innovative product development programs and the company’s recent strong financial